Manuel Vázquez Carrera
Jefe de Grupo Senior
The researcher Manuel Vázquez Carrera graduated in Pharmacy in 1990 from the University of Barcelona and received his Doctor of Pharmacology degree from the University of Barcelona in 1994.
Between 1996 and 2001 he spent a postdoctoral stay at the Institut de Biologie Animale de la Université de Lausanne where he studied the mechanisms of action of the nuclear receptor PPARα.
In 1997 he got a position of full professor at the University of Barcelona and since 2017 he has been full professor of the same university. However, he is a principal researcher at CIBERDEM.
He is currently leading the research group Pharmacological Targets for Inflammation and Metabolic Diseases, where he studies the mechanisms involved in the relationship between inflammation and the development of insulin resistance and diabetic cardiomyopathy.
- Codony S, Calvó-Tusell C, Valverde E, Osuna S, Morisseau C, Loza MI, Brea J, Pérez C, Rodríguez-Franco MI, Pizarro J, Corpas R, Griñán-Ferré C, Pallàs M, Sanfeliu C, Vazquez M, Hammock BD, Feixas F and Vázquez S From the Design to the In Vivo Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute Pancreatitis. JOURNAL OF MEDICINAL CHEMISTRY . 64(9): 5429-5446.
- Aguilar-Recarte D, Palomer FX and Vazquez M Uncovering the role of apolipoprotein C-III in insulin resistance. Clinica e Investigacion en Arteriosclerosis . 33(2): 108-115.
- Zarei M, Aguilar-Recarte D, Palomer FX and Vazquez M Revealing the role of peroxisome proliferator-activated receptor ß/d in nonalcoholic fatty liver disease. METABOLISM-CLINICAL AND EXPERIMENTAL . 114: 154342-154342.